We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.41B
AUM Growth
+$125M
Cap. Flow
-$6.29M
Cap. Flow %
-0.45%
Top 10 Hldgs %
35.33%
Holding
276
New
13
Increased
51
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
CLF icon
Cleveland-Cliffs
CLF
+$3.71M
2
XOM icon
ExxonMobil
XOM
+$2.57M
3
PANW icon
Palo Alto Networks
PANW
+$1.41M
4
NVO
Novo Nordisk
NVO
+$1.2M
5
URI icon
United Rentals
URI
+$909K

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$3.95M
2
VZ icon
Verizon
VZ
+$2.07M
3
NEE icon
NextEra Energy
NEE
+$1.38M
4
INTC icon
Intel
INTC
+$1.28M
5
IBM icon
IBM
IBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 19.24%
3 Financials 13.15%
4 Industrials 11.27%
5 Communication Services 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MER.PRK
226
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$214K 0.02%
8,000
– –
DTE icon
227
DTE Energy
DTE
$28.5B
$203K 0.01%
+1,702
New +$195K
WTM icon
228
White Mountains Insurance
WTM
$5.04B
$203K 0.01%
200
– –
SAM icon
229
Boston Beer
SAM
$1.86B
$202K 0.01%
400
– –
PAA icon
230
Plains All American Pipeline
PAA
$16.4B
$149K 0.01%
16,000
– –
MRKR icon
231
Marker Therapeutics
MRKR
$19.2M
$29K ﹤0.01%
3,010
– –
MTNB icon
232
Matinas BioPharma
MTNB
$1.72M
$18K ﹤0.01%
350
– –
LULU icon
233
lululemon athletica
LULU
$14.5B
– –
-500
Closed -$202K
OGN icon
234
Organon & Co
OGN
$3.58B
– –
-8,177
Closed -$268K
PTPI
235
DELISTED
Petros Pharmaceuticals
PTPI
– –
-88
Closed -$44K
XCUR icon
236
Exicure
XCUR
$8.73M
– –
-111
Closed -$20K
XLRN
237
DELISTED
Acceleron Pharma
XLRN
– –
-22,964
Closed -$3.95M
6 7 8 9
10

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, Neville Rodie & Shaw held 276 positions worth $1.41B, up 9.7% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Neville Rodie & Shaw's Q4 2021 filing shows 13 new, 51 increased, 96 reduced and 8 closed positions. Its largest new stake was Cleveland-Cliffs: 172,300 shares worth $3.75M. The largest sale was Acceleron Pharma, an estimated $3.95M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q4 2021 buy was Cleveland-Cliffs: 172,300 shares worth $3.75M.
  • Neville Rodie & Shaw added most to ExxonMobil in Q4 2021, an estimated $2.57M increase.
  • Neville Rodie & Shaw's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.07M.
  • Neville Rodie & Shaw fully exited Acceleron Pharma in Q4 2021, selling an estimated $3.95M.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $1.41B portfolio in Q4 2021.
  • Neville Rodie & Shaw opened 13 new positions and closed 8 in Q4 2021.
  • Neville Rodie & Shaw's portfolio value rose 9.7% quarter-over-quarter to $1.41B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2021, filed 5 Jan 2022.